Primary breast tumor sections revealed slight decreases in PLD2 staining in the primary breast tumor tissue sections from the samples that received FIPI or VU0155072-2 when compared to vehicle-treated samples (Fig 1D), which is quantified in Fig 1E. This evidence concerns the gene PLD2 and breast neoplasm.